Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PRKCD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ALKBH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPDEF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C22orf29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MIR3916 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930388 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PRR26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSBPL7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMCC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC105369507 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNAPC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SELENBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF4G1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SVIL-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SBSN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on